drugset / Trial / NCT02872857

Subarachnoid Hemorrhage Recovery And Galantamine

NCT02872857

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to examine the effects of the study drug--Galantamine-on patients with subarachnoid hemorrhage (SAH). The study will examine how patients with SAH will tolerate the study drug and how it may improve brain functioning in patients after SAH.

Timeline

Start
2016-09
Primary completion
2019-07-20
Completion
2019-07-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Galantamine Small molecule 8 mg
Subject Galantamine Small molecule 12 mg
Subject Galantamine Small molecule